Hetero
HETEROHyderabad, India· Est.
India’s top generic and biosimilar drug manufacturer with a global API and antiviral portfolio.
Is this your company? Claim your profile to update info and connect with investors.
Claim profileAI Company Overview
India’s top generic and biosimilar drug manufacturer with a global API and antiviral portfolio.
Infectious DiseasesVirologyAntiretroviralBiosimilars
Technology Platform
Vertically integrated API manufacturing combined with advanced process analytical technology and a biosimilar recombinant protein platform for cost‑effective, high‑quality generic and biologic drugs.
Opportunities
Expansion of biosimilar portfolio and scaling of COVID‑19 antivirals in emerging markets provide significant revenue upside.
Risk Factors
Regulatory delays, price erosion in generic markets, and intense competition from other Indian generics firms could constrain margins.
Competitive Landscape
Competes with Sun Pharma, Cipla, and Dr. Reddy’s; differentiates through its massive API capacity, low-cost manufacturing, and strategic global partnerships.